Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information


Menlo Park, USA
1050 Hamilton Court
Menlo Park, CA, 94025


Chief Executive Officer & BOD
Vice President, Biology
Board Member
Board Member
Board Member
Board Member
Chief Scientific Officer
Chief Business Officer
Show All People



3-V Biosciences

3-V Biosciences is a privately held biopharmaceutical company discovering and developing novel therapeutics for the treatment of infectious diseases.

3-V Biosciences was founded by The Column Group (TCG) and Kleiner Perkins Caulfield & Byers (KPCB) in March 2007. In April 2007, the original laboratory was opened in Zürich, Switzerland in close proximity to the company’s founders at the ETH (Swiss Federal Institute of Technology) and the University of Zürich. Host pathway screening began in November 2007 and continues today.

Recent Milestones



3-V Biosciences screenshot
Above: 3-V Biosciences
Uploaded: 10/8/09


  1. 3-V Biosciences, Inc. Secures $30 Million in Series B Funding, Welcomes New Members to Board of Directors ( [edit]
  2. 3-V Biosciences Closes $20M Financing ( [edit]
  3. VC funding: Q4 2012 [edit]
  4. 3-V Biosciences Completes $20M Series CFinancing ( [edit]
Edit This Page
Last Edited 12/6/13

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy